Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Anatara Lifesciences Ltd ( (AU:ANR) ) has provided an announcement.
Anatara Lifesciences Ltd has received $969,455 from the Australian Taxation Office under the Federal Government’s R&D tax incentive scheme. This funding will be used to advance the company’s pre-clinical Proof of Concept studies for its Anti-Obesity project, supporting its efforts to address unmet needs in human health.
More about Anatara Lifesciences Ltd
Anatara Lifesciences Ltd is a company focused on developing and commercializing innovative, evidence-based health products, particularly targeting conditions involving the gastrointestinal tract. The company is committed to delivering tangible outcomes for patients and creating value for shareholders.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$1.71M
For detailed information about ANR stock, go to TipRanks’ Stock Analysis page.